Compared with white and Hispanic individuals, black men and women have about a 10% higher lifetime risk of developing PAD, according to a new risk-prediction tool created by combining data from some of the largest community-based cohorts in the United States.
Visit WebsiteWearable devices and smartphone-based apps are becoming ever more popular for patients who want a personalized tool to track their CV metrics. But a new study takes a different tack, asking: could these technologies play a role in the doctor’s office?
Visit WebsiteIn patients with transient STEMI, where symptoms and ST-segment elevation resolve prior to revascularization, it doesn’t seem to matter whether treatment is immediate or delayed. Both strategies produce similarly good outcomes out to 1 year, new data from the multicenter TRANSIENT trial suggest.
Visit WebsitePARIS, France—New guidelines for the management of diabetes and prediabetes from the European Society of Cardiology (ESC), reflecting the “unprecedented increase in new evidence available in the field,” no longer focus on primary and secondary prevention but rather recommend that physicians treat according to patients’ risk of cardiovascular disease.
Visit WebsitePatients with either severe or moderate aortic stenosis (AS) have poor long-term survival when left untreated, according to data from an Australian registry of nearly 250,000 people presented in a late-breaking trial session at the European Society of Cardiology Congress 2019.
Visit WebsitePARIS, France—Cardiovascular disease remains the leading cause of death worldwide, but cancer has now overtaken heart disease as the biggest killer in Canada, Sweden, Saudi Arabia, and the United Arab Emirates, the four high-income countries included as part of the Prospective Urban Rural Epidemiology (PURE) study.
Visit WebsitePARIS, France—Use of point-of-care genotyping to identify patients who need a more-potent P2Y12 inhibitor is noninferior to a blanket approach of giving prasugrel or ticagrelor to all in terms of thrombotic events and is superior when it comes to bleeding.
Visit WebsitePARIS, France—Long-term follow-up of patients across the spectrum of chronic coronary syndromes (CCS) indicates that rates of cardiovascular death and nonfatal MI are very low, but also that risk factor control is far from optimal in this group.
Visit WebsitePARIS, France—A comprehensive intervention led by nonphysician health workers (NPHW) and supported by family and community members resulted in a significant reduction in systolic blood pressure, LDL cholesterol levels, and cardiovascular disease risk among individuals with hypertension in multiple communities throughout Columbia and Malaysia, the HOPE 4 study showed.
Visit Website